Brase, Jan C.
Bayer (Switzerland)
3 papers on CoChatORCID 0000-0002-1325-2528
Most cited papers
- Verified
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer
Corcoran, R. B., André, T., Atreya, C. E., Schellens, J. H. M., Yoshino, T., Bendell, J. C., Hollebecque, A., McRee, A. J., Siena, S., Middleton, G., et al. (2018) · Cancer Discovery
Colorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways
Cited by 592
- Verified
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Syeda, M. M., Wiggins, J. M., Corless, B. C., Long, G. V., Flaherty, K. T., Schadendorf, D., Nathan, P. D., Robert, C., Ribas, A., Davies, M. A., et al. (2021) · The Lancet Oncology
Melanoma and MAPK PathwaysCancer Genomics and Diagnostics
Cited by 101
- Verified
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
Le, X., Kim, T. M., Loong, H. H., Prelaj, A., Goh, B. C., Li, L., Fang, Y., Lu, S., Dong, X., Wu, L., et al. (2025) · New England Journal of Medicine
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 70
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free